 |
VLA-4 and LFA-1 integrin activator |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant melanoma stages IIB to IV |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-08 00:00:00 |
| Sponsor | 7 Hills Pharma, LLC;8285 El Rio Street, Suite 130;Houston, Texas, 77054 |
| |
VLA-4 and LFA-1 integrin activator |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant melanoma stages IIB to IV |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-08 00:00:00 |
| Sponsor | 7 Hills Pharma, LLC;8285 El Rio Street, Suite 130;Houston, Texas, 77054 |